Tag: CLTI

First results from BEST-CLI poised to reveal ‘very low’ quality of...

An analysis from the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial presented at the 2022 Vascular Annual...

Researchers report higher three-year amputation and reintervention rates in Black and...

In a study of over 7,000 chronic limb-threatening ischemia (CLTI) patients, researchers found that Black and Hispanic patients had higher three-year amputation and reintervention...

Open surgical bypass to distal targets at the ankle is ‘viable’...

The Vascular and Endovascular Surgical Society (VESS) Paper Session at the Vascular Annual Meeting (VAM) in Boston on Wednesday, June 15, will see Othman...

Revascularization strategy for BTK intervention should hinge on diagnostic modality, LINC...

New data provide “another argument” for the use of intravascular ultrasound (IVUS) in below-the-knee (BTK) interventions. This is according to Michael Lichtenberg, MD, from Arnsberg...

Register today for two SVS courses

Registration has opened—along with early-bird pricing—for two Society for Vascular Surgery (SVS) in-person courses in coding and reimbursement, and peripheral artery disease (PAD) skills....

Silent coronary ischemia: FFRCT reduces cardiac death, myocardial infarction in carotid...

Diagnosis of silent, or unsuspected, coronary ischemia in patients undergoing carotid endarterectomy (CEA) using fractional flow reserve-computed tomography (FFRCT), with selective postoperative coronary revascularization,...

FDA grants IDE approval for Selution SLR drug-eluting balloon

MedAlliance’s Selution SLR drug-eluting balloon (DEB) has received investigational device exemption (IDE) approval from the Food and Drug Administration, making it the first limus...

New long-term data of paclitaxel devices continue to show no increased...

New long-term data from the SAFE-PAD (Safety assessment of femoropopliteal endovascular treatment with paclitaxel-coated devices) study were presented today as late-breaking clinical research at...

Tissue samples show paclitaxel effect in minority of CLTI patients receiving...

Paclitaxel effect was witnessed in tissue specimens of a minority of chronic limb-threatening ischemia (CLTI) patients treated with drug-coated balloons (DCBs)—but was not dependent...

Non-optimal therapy for CLTI ‘more prominent in females’

A real-world claims data analysis of nearly 200,000 patients with chronic limb-threatening ischemia (CLTI) showed that female patients were older, underwent vascular procedures less often, and...

SCAI releases multi-society position statement focused on core competencies for endovascular...

The Society for Cardiovascular Angiography & Interventions (SCAI) has released a position statement outlining competencies for endovascular specialists who provide care for chronic limb-threatening...

CLTI, VTE and post-thrombotic syndrome: Leading experts discuss crucial decision-making in...

This advertorial is sponsored by ACHL For Anahita Dua, MBChB, the stark realities and complexities of peripheral arterial disease (PAD) patients undergoing endovascular treatment for...

SCVS 2022: WIfI score does not predict successful healing after transmetatarsal...

A higher initial Wound, ischemia, and foot infection (WIfI) classification score at initial presentation in chronic limb-threatening ischemia (CLTI) patients who underwent a transmetatarsal...

PROMISE II U.S. pivotal trial of device designed for ‘no-option’ CLTI...

Enrollment has been completed in the PROMISE II pivotal trial of the LimFlow deep vein arterialization system designed to prevent amputations in so-called "no-option"...

Cook Medical receives FDA breakthrough designation for new drug-eluting stent

Cook Medical has received Breakthrough Device designation from the Food and Drug Administration (FDA) on a new drug-eluting stent (DES) for below the knee...

ISET 2022 audience hears latest data on endovascular therapies

At this year’s International Symposium on Endovascular Therapy (ISET), being held Jan. 16–19 in Hollywood, Florida, experts presented an array of late-breaking trial results...

CLI at a crossroads: Which direction now?

Vascular surgery once again finds itself at a crossroads, Michael Belkin, MD, chief of the division of vascular and endovascular surgery at Brigham and...

First patient enrolled in Disrupt BTK II study for long, calcified,...

Shockwave Medical has announced the start of the Disrupt BTK II postmarket study to assess the safety, effectiveness and optimal clinical use of the Shockwave...

Philips announces large-scale study outcomes on use of IVUS in peripheral...

Royal Philips has announced the results of a new large-scale real-world analysis of Centers for Medicare & Medicaid Services (CMS) data on the health...

WIfI system helps predict revascularization benefit for diabetic patients with CLTI,...

A retrospective study supports the use of the Wound, ischemia, and foot infection (WIfI) classification system to predict the revascularization benefit for diabetic patients with chronic limb-threatening ischemia...

PROMISE I 24-month results ‘validate the benefits of the LimFlow system’

LimFlow has announced 24-month results from the PROMISE I study of the LimFlow percutaneous deep vein arterialization system, confirming “excellent and sustained outcomes” for...

VIVA 2021: IVL ‘consistently’ treats real-world calcium in multiple peripheral vessel...

An interim analysis from the DISRUPT PAD III observational study showed that intravascular lithotripsy (IVL) performs “consistently well” across challenging peripheral vessels, lesions and...

‘Proceed cautiously in use of DCBs in CLTI patients with advanced...

The last several years have seen ongoing controversy and debate about the risks and benefits of paclitaxel-coated devices (PCDs) for patients with peripheral arterial...

PAD: R3 Vascular reports ‘successful initiation’ of first-in-human study of bioresorbable...

Medical device developer R3 Vascular has reported the "successful initiation" of a first-in-human clinical study evaluating the technical and clinical performance of its Magnitude...

VAM discussion on latest paclitaxel meta-analysis yields mix of caution, skepticism

A Vascular Annual Meeting (VAM) sponsored session on paclitaxel safety drew a mix of skeptical and cautious responses to the latest meta-analysis from interventional...

Veterans with claudication who undergo revascularization ‘significantly more likely to have...

Patients within the Veterans Affairs Administration healthcare system who underwent an intervention for intermittent claudication (IC) were consistently at three-to-four times greater risk of...

PRISTINE registry with Selution SLR sirolimus drug-eluting balloon completes enrollment

MedAlliance has announced completion of patient enrollment in the PRISTINE clinical trial with the Selution SLR 018 drug-eluting balloon (DEB) for the treatment of patients with below-the-knee...

LimFlow system a ‘cost-effective and high-value alternative’ to traditional therapies

Percutaneous deep vein arterialization (pDVA) with the LimFlow system offers a cost-effective and high-value alternative to traditional therapies or amputation, according to a recent...

Latest meta-analysis on paclitaxel in peripheral arterial disease provokes mixed reception

“There appears to be heightened risk of major amputation after use of paclitaxel-coated balloons in the peripheral arteries,” findings from a systematic review...

Introducing patient-reported outcomes into the VQI

Vascular specialists have long recognized that there is more to the treatment of peripheral arterial disease (PAD) than the immediate procedural success and early...

Philips announces positive two-year data from TOBA II BTK clinical trial

Royal Philips recently announced positive two-year results from the TOBA (Tack optimized balloon angioplasty) II below-the-knee (BTK) clinical trial. The data show the Philips Tack endovascular...

One-year results from PROMISE I study of LimFlow system in ‘no-option’...

Twelve-month data from the full patient cohort in the PROMISE I study of the LimFlow percutaneous deep vein arterialization (pDVA) system have been...

Intermittent claudication and exercise therapy: A poor SET-up

Many of you may have already heard about the controversial Comparative Billing Reports (CBRs) that have been received by some of our vascular surgery...

Innovation: ISET audience hears what’s on the horizon for CLTI patients

“I am going to give you reasons to be excited about your critical limb practice,” Peter Schneider, MD, professor of vascular and endovascular surgery...

MicroStent to treat PAD below the knee receives FDA breakthrough device...

Micro Medical Solutions (MMS) recently revealed Food and Drug Administration (FDA) breakthrough device designation for its MicroStent vascular stent. This novel technology is designed...

Lessons in PAD care from VA vascular surgeons

The care of patients with peripheral arterial disease (PAD) is challenging and costly. Every practicing vascular surgeon knows that when patients present with ulcerations,...

‘A reliable tool’: Positive findings for 2D perfusion angiography in CLTI...

Researchers suggest that in patients with chronic limb-threatening ischemia (CLTI), two-dimensional (2D) perfusion angiography is a “reliable tool” when used according to standardized methods. Jetty...

Study identifies ‘critical need’ for guidelines on appropriate use of atherectomy

No data currently exist to support the use of atherectomy over other procedures for the treatment of peripheral arterial disease (PAD), and the healthcare...

Patients with depression ‘less likely’ to go home after CLTI revascularization

A recent analysis established an association between depression and non-home discharge after revascularization for chronic limb-threatening ischemia (CLTI)—providing further evidence, the authors say, that...

WIfI score found to be accurate across racial groups

The wound, ischemia and foot infection (WIfI) score is as accurate a predictor of risk for limb loss in Black people as it is...

SWEDEPAD unplanned interim analysis shows no difference in all-cause mortality for...

An unplanned interim analysis of the registry-based SWEDEPAD clinical trial, in which patients with peripheral arterial disease (PAD) received treatment with paclitaxel-coated (drug-coated balloons...

The benefits of an academic research career in the VA

Every year a number of graduating vascular trainees look for jobs in academic surgery to develop a career as a surgeon-scientist in basic, translational...

SVS pushes out trio of mobile apps to aid CLTI treatment

The Society for Vascular Surgery (SVS) has launched three new mobile apps to help guide surgeons in the treatment and management of chronic limb-threatening...

Foot vein arterialization study shows 77.8% limb salvage rate

Foot vein arterialization (FVA) is a safe procedure with good early graft patency and a limb salvage rate of 77.8%, Qi Yan, MD, and...

Diabetes Awareness Month: The utility of SVS branding fliers for diabetic...

November is Diabetes Awareness Month. The Branding Toolkit can help SVS members promote the valuable care they provide those with the disease. One of...

Previously described patient-centered clinical success measure after revascularization for diabetic foot...

Patient-centered clinical success after lower-extremity revascularization for people with diabetic foot wounds was achieved among 63% of patients in a new analysis—but researchers suggest...

Utilize new SVS Branding Toolkit

The new SVS Branding Toolkit—a robust set of tools designed to help members communicate their roles in comprehensive vascular care—is now available exclusively and...

CDC codifies CLI, CLTI in ICD-10-CM

The Centers for Disease Control and Prevention (CDC) has approved a proposal to distinctly recognize critical limb ischemia (CLI) and critical limb-threatening ischemia (CLTI)...

VA system delivers high quality services for veterans

Vascular surgery in the Veterans Health Administration has always been a robust service, developing into a mature specialty around the time of the Vietnam...

Medicare reimbursement fails to adequately cover cost of care after open...

For most patients with chronic limb-threatening ischemia (CLTI), Medicare reimbursement for lower extremity bypass surgery does not adequately account for case complexity in the...

‘Rapid reduction’ in amputations follows opening of multidisciplinary limb preservation service

A multidisciplinary limb preservation service under the leadership of vascular surgery in a level one trauma center was associated with an immediate and rapid...

Three weeks remain of VQI virtual sessions

SVS ONLINE—the virtual meeting staged by the Society for Vascular Surgery (SVS)—may be completed, but the Vascular Quality Initiative (VQI) virtual sessions have three...

Positive two-year data from ALPS registry of LimFlow system published

LimFlow SA today announced publication of positive two-year data from the ALPS registry of the LimFlow percutaneous deep vein arterialization (pDVA) system. Results were published...

Quality: Global Vascular Guidelines pocket guide coming soon

The Global Vascular Guidelines (GVG), extensively researched and written by an international committee of leading vascular experts, will soon be available as a pocket...

Study: Link between IC revascularization and progression to CLTI established alongside...

PALM BEACH, Fla.—Revascularization of intermittent claudication (IC) patients is associated with an increased rate of progression to critical limb-threatening ischemia (CLTI)—as well as an...

New meta-analysis finds ‘no observed difference’ in mortality between paclitaxel and...

February 2020 brings another paclitaxel device meta-analysis of randomized controlled trials in chronic limb-threatening ischemia (CLTI) patients. Krystal Dinh, BMed, of Westmead Hospital, Sydney,...
Richard Neville

Global vascular guidelines for CLTI are gaining traction but work remains...

The application of new global vascular guidelines for chronic limb-threatening ischemia (CLTI) provides an opportune and worthwhile window to revisit the concept of critical...